Protalix Biotherapeutics Inc (PLX) stock news · rev $52.7M
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
This PLX news page leads with what Protalix Biotherapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for PLX yet. We will not pad this page with generic market recap.
Latest reported PLX revenue for 2025-12-31 was $52.7M. Net income was -$6.6M. Revenue was down 1.2% from 2024-12-31 to 2025-12-31. PLX currently screens at market cap $122.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PLX stock page; for the tape open the quote page.
PLX stock news FAQ
What are PLX's latest revenue and net income?
Latest cached Protalix Biotherapeutics Inc (PLX) revenue for Dec 31, 2025 was $52.7M. Net income was -$6.6M. Statements: https://lician.com/financials/plx
How did PLX revenue change from the prior cached period?
Cached Protalix Biotherapeutics Inc (PLX) revenue was down 1.2% from $53.4M (Dec 31, 2024) to $52.7M (Dec 31, 2025). Statements: https://lician.com/financials/plx
What is PLX's market cap?
Protalix Biotherapeutics Inc (PLX) market cap is $122.6M on the latest cached fundamentals snapshot.
What kind of company is PLX?
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Where is PLX stock news listed?
Cached stock news for Protalix Biotherapeutics Inc (PLX) is listed at https://lician.com/news/plx. Filings: https://lician.com/sec/plx
Not investment advice.